Max Robotics — Global Service Robot Directory + US Certification

About

Michele Lodde is a urologic surgeon whose research spans the evolution of prostate cancer surgery, postoperative pain management, and the impact of dietary supplements on surgical outcomes. His work critically examines both established and emerging practices in uro-oncology. Lodde’s most cited study, “Radical perineal prostatectomy: An outdated procedure?” (2011, 14 citations), defends the perineal approach as a viable, minimally invasive alternative to retropubic, laparoscopic, or robotic prostatectomy, detailing its technical aspects, oncological outcomes, and complication rates. More recently, he has addressed the opioid crisis in “Opioids use after uro-oncologic surgeries in time of opioid crisis” (2022, 3 citations), a prospective study highlighting the need for standardized prescribing guidelines to reduce overprescription and opioid-related harm. In “Effects of omega-3 fatty acids supplementation on perioperative blood loss and complications after radical prostatectomy” (2021, 3 citations), Lodde challenges the common practice of discontinuing omega-3 supplements before surgery, finding no significant increase in bleeding risk—a finding that could improve perioperative care and patient quality of life. His work demonstrates a commitment to evidence-based, patient-centered surgical innovation.